Month: May 2021

Achieved First Quarter 2021 Average Production of 24,463 BOPD, Up 12% from Prior Quarter Increased Current Average Production to 28,200 BOPD 2020 Sustainability Report Published Reaffirms 2021 Full-Year Production Guidance of 28,000-30,000 BOPD and Capital of $130-150 Million Increases 2021 Full-Year Budget Guidance: Cash Flow2 of $205-225 Million, Free Cash Flow2 of $75 Million, EBITDA1 of $255 – $275 MillionCALGARY, Alberta, May 04, 2021 (GLOBE NEWSWIRE) — Gran Tierra Energy Inc. (“Gran Tierra” or the “Company”) (NYSE American:GTE)(TSX:GTE)(LSE:GTE) today announced the Company’s financial and operating results for the quarter ended March 31, 2021 (“the Quarter”). All dollar amounts are in United States dollars and production amounts are on an average working interest before royalties (“WI”) basis unless otherwise indicated....

Not for distribution, directly or indirectly, in the United States, Australia or Japan MONTREAL, May 04, 2021 (GLOBE NEWSWIRE) — Bombardier Inc. (“Bombardier”) announces the successful sale of 11,504,149 shares in Alstom S.A. (“Alstom”), representing 3.1% of Alstom share capital, at a price of €44.00 per share (i.e., a total amount of €506 million) in an accelerated bookbuilt offering to qualified investors as defined in Article 2 point (e) of Regulation (EU) 2017/1129, as amended (the “Offering”). Following the settlement of the Offering, Bombardier will have fully exited its stake in Alstom’s common stock. Settlement of the Offering should take place on May 7, 2021. Alstom shares are listed on the regulated market of Euronext in Paris (ISIN code: FR0010220475). DISCLAIMER This press release is for information purposes only and...

GUADALAJARA, Mexico, May 04, 2021 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacifico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announces preliminary terminal passenger traffic figures for the month of April 2021. Starting this month, we will include comparisons with the 2019 and 2020 figures, to facilitate the reading and understanding of the passenger traffic trend. For April 2021, the total number of terminal passengers at GAP’s 12 Mexican airports decreased by 15.7%, compared to the same period of 2019. It is important to highlight that the Tijuana airport presented an increase in passenger traffic of 7.1%, while the Los Cabos, Guadalajara and Puerto Vallarta airports presented a decrease of only 12.7%, 21.5% and 32.9%, respectively, which demonstrate a positive trend in our main airports. Passenger traffic...

VANCOUVER, British Columbia, May 04, 2021 (GLOBE NEWSWIRE) — Ero Copper Corp. (TSX: ERO) reported the voting results from its annual general meeting of shareholders held today in a virtual-only format conducted by live audio teleconference. A total of 78,557,201 common shares were represented at the meeting, being 89.17% of the issued and outstanding common shares of the Company as at the March 12, 2021 record date. Shareholders voted in favour of all items of business before the meeting, including the re-election of management’s nominees as directors for the ensuing year and the advisory vote on executive compensation. Detailed results of the votes are presented below. Each item of business voted upon at the meeting is described in detail in the Company’s Management Information Circular dated March 16, 2021 (the “Circular”),...

ROCKVILLE, Md., May 04, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that Newron Pharmaceuticals S.p.A. (“Newron”) received a Paragraph IV Notice Letter (“Notice Letter”) from Aurobindo Pharma Limited, India and its wholly owned subsidiary Aurobindo Pharma USA Inc. (collectively “Aurobindo”), advising Newron of the filing by Aurobindo of an Abbreviated New Drug Application to the U.S. Food and Drug Administration (“FDA”) seeking approval for safinamide tablets. The Notice Letter is directed to the three XADAGO patents with U.S. patent numbers 8,076,515, 8,278,485 and 8,283,380, that expire between June 2027 and December 2028 and are listed in the FDA’s...

RANCHO CORDOVA, Calif., May 04, 2021 (GLOBE NEWSWIRE) — Five Star Bancorp (“Five Star” or the “Company”), announced today the pricing of the initial public offering of 5,265,000 shares of its common stock, at a public offering price of $20.00 per share for expected net proceeds to the Company, after deducting the underwriting discount and estimated offering expenses, of approximately $94.8 million. The shares are expected to begin trading on Wednesday, May 5, 2021 on the Nasdaq Global Select Market under the symbol “FSBC.” The offering is expected to close on or about May 7, 2021, subject to the satisfaction of customary closing conditions. The Company has granted the underwriters a 30-day option to purchase up to an additional 789,750 shares of common stock, at the initial public offering price of $20.00 per share, minus the underwriting...

CALGARY, Alberta, May 04, 2021 (GLOBE NEWSWIRE) — Athabasca Oil Corporation (TSX: ATH) (“Athabasca” or the “Company”) is pleased to report its 2021 first quarter results that demonstrate the resilience and quality of its asset base. The Company is also pleased to provide an update on initiatives to further improve its positioning in a post COVID recovery. Athabasca plans to refinance its debt in the coming months that will allow shareholders to capture the unparalleled cashflow generation potential from its long reserve life, oil weighted asset base. Q1 HighlightsProduction: ~34,400 boe/d including ~25,950 bbl/d in Thermal Oil and ~8,450 boe/d in Light Oil. Operating Income: $66 million driven by stronger oil prices and high liquids weighting (89%). Adjusted Funds Flow: $19 million ($0.04 per share). Capital Expenditures: $36...

On track to refile Libervant™ (diazepam) Buccal Film New Drug Application (NDA) by end of second quarter 2021 Initiated first-in-human Phase 1 pharmacokinetic (PK) study for AQST-109 epinephrine sublingual film candidate Sympazan® (clobazam) continues to meet key performance metrics and gain market share Hosts conference call at 8:00 a.m. ET on May 5, 2021WARREN, N.J., May 04, 2021 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, today reported financial results for the first quarter ended March 31, 2021 and provided an update on recent developments in its business. “We are focused on continuing to make progress this year in advancing our proprietary products....

VANCOUVER, British Columbia, May 04, 2021 (GLOBE NEWSWIRE) — Trailbreaker Resources Ltd. (TBK.V) (“Trailbreaker” or “the Company”) is pleased to announce that, subject to regulatory approval, it has closed their private placement financing consisting of Hard Dollar Units and Flow-Through Units, for total gross proceeds of $1,048,610, an increase of $48,610 more than originally anticipated. Both offerings received support from strategic accredited investors. The Company has closed on 800,000 non-flow-through Units for gross proceeds of $200,000 (the “Units”), each $0.25 Unit priced consisting of 1 common share of the Company and 1 common share purchase warrant (the “Unit Warrants”), each Unit Warrant being exercisable for an additional common share of the Company at $0.39 for 24 months from closing, subject to the right of the Company...

BROOMFIELD, Colo., May 04, 2021 (GLOBE NEWSWIRE) — DMC Global Inc. (Nasdaq: BOOM) (“DMC Global”) today announced the pricing of its underwritten public offering of 2,500,000 shares of common stock at a public offering price of $45.00 per share. DMC Global has also granted the underwriters a 30-day option to purchase up to 375,000 additional shares of common stock on the same terms. The gross proceeds to DMC Global from this offering are expected to be approximately $112.5 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by DMC Global, and assuming no exercise of the underwriters’ option to purchase additional shares of common stock. The offering is expected to close on or about May 7, 2021, subject to satisfaction of customary closing conditions. All of the shares...